Madrigal appoints J&J R&D chief John Reed to board

Reuters2026/08/12 12:03

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Madrigal Pharmaceuticals appointed John C. Reed to its board of directors on Aug. 12, 2026.
Reed is executive vice president, Innovative Medicine, Research & Development at Johnson & Johnson.
He joined J&J in April 2023 following executive roles at Sanofi, Roche, and Sanford-Burnham Medical Research Institute.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Madrigal Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608120800PRIMZONEFULLFEED9808337) on August 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Madrigal appoints J&J R&D chief John Reed to board

You may also like

Crypto prices